ARCHIVES

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

This article is from The Cancer Letter archive.

Vol. 07 No. 45 | November 6, 1981

Download PDF Visit The Full Archive

Related Articles

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Beyond Planned Parenthood: Attendance Flags at Komen Flagship Race, D.C. Participation Drops by Nearly One-Third

June 8, 2012

NIH Alternative Medicine Officer Under Fire For Proposed RFA In Homeopathy, Acupuncture

February 26, 1993

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992